Newsroom

Second allowance covers its unique insulin administration method. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application directed toward a method of administering insulin proven to improve patient outcomes compared to...

The allowed claims are directed to a system for glycemic control of a diabetic patient that includes a smartphone-based diabetes mobile application, which will provide patients with real-time insulin dosing guidance, leveraging Glytec’s proprietary insulin titration technology. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions,...